| Nov 04, 2013
The American Society of Addiction Medicine (ASAM) applauds the FDA’s recommendation to reschedule hydrocodone combination products into a more tightly controlled class of narcotics. ASAM has advocated for the change since September 2011, when it sent a letter to the FDA Commissioner in response to an Associated Press news story that called the level of hydrocodone abuse a “national crisis.”
ASAM recognizes the important role that opioid analgesics play in the management of chronic, severe pain. However, most opioid analgesic prescribers have had little to no formal pain management or addiction treatment training. According to Dr. Brad Hall, a little education about pain management and addiction risk evaluation could go a long way toward stemming the opioid epidemic and overdose rates.
Read ASAM’s press release here.